股票行情快报：通策医疗（600763）11月3日主力资金净卖出168.85万元

Core Viewpoint - Tongce Medical (600763) experienced a slight decline in stock price, closing at 43.31 yuan on November 3, 2025, with a trading volume of 42,500 hands and a total transaction amount of 184 million yuan [1] Group 1: Financial Performance - For the first three quarters of 2025, Tongce Medical reported a main business revenue of 2.29 billion yuan, a year-on-year increase of 2.56% [3] - The net profit attributable to shareholders for the same period was 514 million yuan, up 3.16% year-on-year [3] - The third quarter of 2025 saw a single-quarter main business revenue of 842 million yuan, reflecting a year-on-year increase of 2.34% [3] - The company’s gross profit margin stood at 41.69%, significantly higher than the industry average of 35.56% [3] Group 2: Market Position and Valuation - Tongce Medical's total market capitalization is 19.372 billion yuan, ranking 8th in the medical services industry [3] - The company has a price-to-earnings ratio (P/E) of 28.29, which is considerably lower than the industry average of 382.07, ranking 3rd in the industry [3] - The return on equity (ROE) for Tongce Medical is 11.8%, significantly higher than the industry average of 3.24%, ranking 5th in the industry [3] Group 3: Fund Flow Analysis - On November 3, 2025, the net outflow of main funds was 1.6885 million yuan, accounting for 0.92% of the total transaction amount [2] - Over the past five days, the stock has seen fluctuations in fund flows, with notable net inflows and outflows from different investor categories [2] - The average target price set by institutions over the past 90 days is 52.01 yuan, with 7 buy ratings and 2 hold ratings [4]